Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Detlef H Krieter

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Artificial Organs|January 8, 2014
Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysisDetlef H Krieter, Eric Devine, Christoph Wanner, et al.
Artificial Organs|February 22, 2021
Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and ethylene-vinyl alcohol copolymer membranesDetlef H Krieter, Jarline Jeyaseelan, Marieke Rüth, et al.
Kidney International|December 22, 2004
Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltrationDetlef H Krieter, Sven Falkenhain, Lotfi Chalabi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyAndreas Schneider, Christiane Drechsler, Vera Krane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2010
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapyDetlef H Krieter, Regina Fischer, Karin Merget, et al.
Artificial Organs|April 23, 2015
Pharmacokinetics of Certoparin During In Vitro and In Vivo DialysisDetlef H Krieter, Susanne Fink, Oliver Dorsch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysisVera Krane, Detlef H Krieter, Manfred Olschewski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2006
Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteinsDetlef H Krieter, Andreas Morgenroth, Artur Barasinski, et al.
Plos One|May 30, 2015
Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized TrialAndreas Schneider, Markus P Schneider, Detlef H Krieter, et al.
BMC Nephrology|June 30, 2012
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane studyOliver Dorsch, Detlef H Krieter, Horst-Dieter Lemke, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Artificial Organs|January 8, 2014
Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysisDetlef H Krieter, Eric Devine, Christoph Wanner, et al.
Artificial Organs|February 22, 2021
Clinical hemocompatibility of double-filtration lipoprotein apheresis comparing polyethersulfone and ethylene-vinyl alcohol copolymer membranesDetlef H Krieter, Jarline Jeyaseelan, Marieke Rüth, et al.
Kidney International|December 22, 2004
Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltrationDetlef H Krieter, Sven Falkenhain, Lotfi Chalabi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 19, 2011
The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyAndreas Schneider, Christiane Drechsler, Vera Krane, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 29, 2010
Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapyDetlef H Krieter, Regina Fischer, Karin Merget, et al.
Artificial Organs|April 23, 2015
Pharmacokinetics of Certoparin During In Vitro and In Vivo DialysisDetlef H Krieter, Susanne Fink, Oliver Dorsch, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysisVera Krane, Detlef H Krieter, Manfred Olschewski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 20, 2006
Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteinsDetlef H Krieter, Andreas Morgenroth, Artur Barasinski, et al.
Plos One|May 30, 2015
Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized TrialAndreas Schneider, Markus P Schneider, Detlef H Krieter, et al.
BMC Nephrology|June 30, 2012
A multi-center, prospective, open-label, 8-week study of certoparin for anticoagulation during maintenance hemodialysis--the membrane studyOliver Dorsch, Detlef H Krieter, Horst-Dieter Lemke, et al.
Pageof 3